CALL TO ACTION: Protect cBHT!
FDA is threatening cBHT restrictions. Urge your member of Congress to weigh in — we make it easy.
FDA is threatening cBHT restrictions. Urge your member of Congress to weigh in — we make it easy.
ICYMI: Two federal courts separately denied requests from plaintiffs who wanted to force FDA to authorize the use of hydroxychloroquine to treat or prevent Covid-19 — despite the fact that there is little to no evidence that it works, and may even be dangerous.
The new blog post from Gus Bassani, PCCA's chief scientific officer, explains "Why Brand and Generic Substitution Is Not the Same as Raw Material Substitution".
Compounders on Capitol Hill is still going on — we're in the midst of our 55 virtual congressional meetings, and we're getting great feedback as we're having our voice heard loud and clear.
Three major pharmacy associations — APC, NCPA, and NASPA — have submitted a joint letter today to the FDA, expressing concern about the NASEM study of cBHT and FDA’s stated intention of considering restrictions based on that study.
Urologists at Wake Forest University are working to improve the use of intracavernosal Injection (ICI) for erectile dysfunction — they're looking for help from compounders to improve understanding among urologists relative to ICI, "and to try and standardize our delivery of care relative to treatment and education."
Jeffrey Bray, CPhT, of Salt Lake City, was the recipient of the Alliance for Pharmacy Compounding's first annual George and Lucy Malmberg Compounding Advocacy Champion Award, presented to him at APC's Compounders on Capitol Hill event on September 10.
Four representatives — Jaime Herrera Beutler, Henry Cuellar, Mark Pocan, and David P. Roe, M.D. — have written a letter to FDA Commissioner Stephen Hahn expressing their concern with the NASEM report.
Great news: HHS is preemptively authorizing pharmacists and pharmacy interns across the country to administer any approved Covid-19 vaccine to patients 3 and older.
You want to be able to ship meds out of state? You want to continue to supply veterinary compounds? You want cBHT to stay legal? THEN SAY SO. Start at Compounders on Capitol Hill this Thursday.
"The long muscle fibers that keep hearts beating were diced into short bits": that's what even mild cases of Covid-19 can do. Supplements can help — learn how with our September 29 webinar.
The APC Board of Directors this week approved a reinvigorated Compounder Code of Ethics and a requirement that APC members indicate that they will abide by the tenets of the code as a condition of membership in APC.
USP has announced its next step as it reconsiders the BUD provisions in General Chapters <795> and <797>, following APC's successful appeal last year. Next up: An all-day virtual public forum on Tuesday, September 15 where USP will share its current findings, then take questions, comments, recommendations from participants that will inform the 2020 – 2025 Compounding Expert Committee, chaired by APC member Brenda Jensen. Click here to register for the forum. Got questions? Contact the USP Healthcare Quality and Safety staff at CompoundingSL@usp.org.
Tricare is refusing to back down. We’re still fighting, don’t worry — and we’ve added new information to our resources page (and available to both members and non-members). The most important points...
Meet her at our CompPAC fundraiser reception.
Unlike some other organizations, the folks at Boston Children's Hospital want to make it easier for kids to get vaccinated. So make sure your pharmacy is on VaccineFinder — a national registry that helps parents find the closest and most convenient place to get their kids the shots they need: Click here to register.
Working with our grassroots organization, the Partnership for Personalized Prescriptions (P3), APC has created a Patient Testimonial Portal where cBHT patients (as well as prescribers and compounders) can share their cBHT experiences.
We're still working hard to get as many members of Congress to sign onto the Norcross/Pocan/Yoho "Dear Colleague" letter to FDA. Has yours signed it? Make sure they have.
The Department of Health and Human Services has given pharmacists in all 50 states — regardless of state laws or regulations — .
Created this year by the APC Board of Directors to honor long-time compounding advocates George and Lucy Malmberg, APC is proud to announce a call for nominations for the the inaugural George & Lucy Malmberg APC Advocacy Champion Award.
Compounding pharmacist (and APC member) Diana Harshbarger is almost certain to be elected to Congress this November.
The coalition is dedicated to demonstrating the safety and effectiveness of compounded bioidentical hormone therapy and preserving its place as a treatment option for millions of Americans. It will do that through a combination of advocacy, communications, and presentation of compelling scientific data. The goal: a regulatory framework in which cBHT remains a viable, accessible treatment option for patients.
Congratulations to the first winners of the new Pharmacy Compounding Foundation and Pharmacists Mutual Compounding Scholarship!
Finally! Guess what, 503B pharmacies? The FDA is — after half a decade -- considering updating the bulk drug substances list, and it wants your input.
Three members of Congress — Ted Yoho (R-FL, also a veterinarian), Mark Pocan (D-WI), and Donald Norcross (D-NJ) — have written a “Dear Colleague” letter to their peers, asking for signatures on a letter to FDA Commissioner Stephen Hahn. They want Hahn to withdraw GFI #256. Contact your member of Congress and ask them to contact Norcross, Pocan, or Yoho to sign this letter.
Don't forget: APC and the Ohio Pharmacists Association have joined forces for the Compound Conference — part of the Midwest Independent Pharmacy Expo, October 3 and 4 in Columbus, Ohio or virtually. It's two conferences in one: Oct 3 is for indy pharmacists, and Oct 4 is just for compounders. Register for one or both!
Worth a read: Small distilleries and hand sanitizer -- a "messy financial calculus". They stepped up when Covid-19 first appeared, but a confusing response from the feds and a fluctuating future has left them in a financial and production limbo.
Okay, so CMS will now compensate “healthcare providers” for telling — sorry, counseling patients to stay home during the pandemic, but won’t compensate pharmacists as providers for the extraordinary counsel they provide their patients every day on medications, diet, exercise, and more. Yeah, that makes sense.
We've got a new live CE webinar in partnership with APMS that's pretty darned timely: "Putting Safety at the Center of Your Compounding Operation." It's Tuesday, August 11 from 2:00 - 3:00 pm EDT. Get the deets and sign up at A4PC.org/safetycenter.
Kodak is getting a $765 million loan to create “starter materials” and active pharmaceutical ingredients using its extensive chemical expertise, as part of a long-term plan to reduce U.S. reliance on Chinese ingredients.